missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Please login to your online account to display your discounted pricing
Adenosine-5'-Diphosphate Disodium Salt, MP Biomedicals™
Involved in energy storage and nucleic acid metabolism. Adenosine-5'-Diphosphate Disodium Salt, MP Biomedicals is an adenine nucleotide that converts into ATP by ATP synthases. ADP affects platelet activation through its interaction with ADP receptors.
$167.00 - $167.00
Chemical Identifiers
CAS | 16178-48-6 |
---|---|
Molecular Formula | C10H13N5Na2O10P2 |
Molecular Weight (g/mol) | 471.17 |
MDL Number | MFCD00150927 |
InChI Key | ORKSTPSQHZNDSC-WCYUCLFNNA-L |
Synonym | adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate |
PubChem CID | 85315 |
IUPAC Name | disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate |
SMILES | [Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 |
Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
MP21000565
|
MP Biomedicals Inc
021000565 |
500 mg |
Each for $167.00
|
|
|||||
Description
ADP affects platelet activation through its interaction with ADP receptors P2Y1, P2Y12 and P2X1. Upon its conversion to adenosine by ecto-ADPases, platelet activation is inhibited via adenosine receptors.
Chemical Identifiers
16178-48-6 | |
471.17 | |
ORKSTPSQHZNDSC-WCYUCLFNNA-L | |
85315 | |
[Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 |
C10H13N5Na2O10P2 | |
MFCD00150927 | |
adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate | |
disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate |
Specifications
16178-48-6 | |
MFCD00150927 | |
adenosine 5'-diphosphate disodium salt, adenosine-5'-diphosphate disodium salt, sodium 2r,3s,4r,5r-5-6-amino-9h-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl methyl hydrogendiphosphate, adenosine 5'-diphosphate disodium salt hydrate, adenosine, 5'-diphosphoric acid, disodium salt, adenosine 5'-trihydrogen diphosphate , disodium salt, trinosin s hydrate, disodium hydrogen 2r,3s,4r,5r-5-6-aminopurin-9-yl-3,4-dihydroxyoxolan-2-yl methyl phosphonato oxyphosphonate, adenosine 5'-trihydrogen diphosphate , sodium salt 1:2, disodium adp hydrate | |
[α]20/D -29.6±1° c = 0.5% in 0.5M Na2HPO4 (Lit.) | |
disodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate | |
85315 | |
≥95% |
C10H13N5Na2O10P2 | |
500 mg | |
ORKSTPSQHZNDSC-WCYUCLFNNA-L | |
[Na+].[Na+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1 | |
471.17 | |
471.2 | |
Powder |
Safety and Handling
Recommended Storage : Store at −20°C.